Cano Health Inc. [NYSE: CANO] price surged by 6.47 percent to reach at $0.09. The company report on January 2, 2023 that MSP Recovery, Now Doing Business as LifeWallet, Entered into a Term Sheet for the Monetization of a Portion of Its Company-owned Assignor Interests as a New Source of Monetization for $275 Million, and Payment of $48 Million in Servicing Fees for 2023.
In the ordinary course of its business, LIFW acquires assignments of recoveries from health insurance payors, healthcare providers and others, and uses its proprietary multi-level data analytics system to identify and then works to secure recoveries from responsible parties. LIFW typically obtains the assignment of all of the claim rights and pays out 50% of such recoveries (the “Assignor Interest”) as a contingent payment and retains the other 50% (the “MSPR Recovery Proceeds”). In certain circumstances, LIFW has acquired the assignor’s 50% interest up-front by purchasing the assignor’s contractual right to collect at the time of recovery. LIFW has been able to establish a price for these purchases that inures to the benefit of LIFW by monetizing these claims at a much higher rate than paid by the Company. Today, LIFW announces that it entered into a Term Sheet relating to the sale of $275 million worth of select healthcare claims recovery interests (the “MSP Claims”) and the receipt of another $48 million in servicing fees related to the MSP Claims that LIFW is selling, therefore indicating that these claims, upon signing the definitive documents described herein, will be monetized at a much higher rate than they are purchased for. The Term Sheet also provides for the Company to acquire certain claims for $330 million that pertain to the entire claim rights, as well as certain Assignor Interests.
A sum of 9411649 shares traded at recent session while its average daily volume was at 13.27M shares. Cano Health Inc. shares reached a high of $1.51 and dropped to a low of $1.33 until finishing in the latest session at $1.48.
The one-year CANO stock forecast points to a potential upside of 64.59. The average equity rating for CANO stock is currently 2.70, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Cano Health Inc. [CANO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CANO shares is $4.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CANO stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Cano Health Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 06, 2023. The new note on the price target was released on January 05, 2023, representing the official price target for Cano Health Inc. stock. Previously, the target price had yet another raise to $1.50, while BofA Securities analysts kept a Underperform rating on CANO stock.
The Average True Range (ATR) for Cano Health Inc. is set at 0.18, with the Price to Sales ratio for CANO stock in the period of the last 12 months amounting to 0.28. The Price to Book ratio for the last quarter was 0.85, with the Price to Cash per share for the same quarter was set at 0.05.
CANO Stock Performance Analysis:
Cano Health Inc. [CANO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 39.62. With this latest performance, CANO shares gained by 15.62% in over the last four-week period, additionally sinking by -73.85% over the last 6 months – not to mention a drop of -79.73% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CANO stock in for the last two-week period is set at 51.00, with the RSI for the last a single of trading hit 60.24, and the three-weeks RSI is set at 44.19 for Cano Health Inc. [CANO]. The present Moving Average for the last 50 days of trading for this stock 1.7444, while it was recorded at 1.3540 for the last single week of trading, and 4.8099 for the last 200 days.
Insight into Cano Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Cano Health Inc. [CANO] shares currently have an operating margin of -5.89 and a Gross Margin at +9.29. Cano Health Inc.’s Net Margin is presently recorded at -1.12.
Return on Equity for this stock declined to -4.03, with Return on Assets sitting at -1.27.
Cano Health Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 1.60.
Cano Health Inc. [CANO] Insider Position Details
There are presently around $243 million, or 68.60% of CANO stock, in the hands of institutional investors. The top three institutional holders of CANO stocks are: FMR LLC with ownership of 34,787,577, which is approximately 11.634% of the company’s market cap and around 11.80% of the total institutional ownership; JPMORGAN CHASE & CO, holding 15,886,491 shares of the stock with an approximate value of $23.51 million in CANO stocks shares; and VANGUARD GROUP INC, currently with $21.73 million in CANO stock with ownership of nearly -7.28% of the company’s market capitalization.
Positions in Cano Health Inc. stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 107 institutional holders increased their position in Cano Health Inc. [NYSE:CANO] by around 29,564,525 shares. Additionally, 69 investors decreased positions by around 31,252,901 shares, while 23 investors held positions by with 103,197,557 shares. The mentioned changes placed institutional holdings at 164,014,983 shares, according to the latest SEC report filing. CANO stock had 53 new institutional investments in for a total of 14,619,320 shares, while 24 institutional investors sold positions of 11,407,338 shares during the same period.